Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA A-fib meeting: FDA will host a public "think tank" meeting on the development of an atrial fibrillation registry on April 27 and 28 at its White Oak, Md., headquarters, Cardiac Electrophysiology and Monitoring Devices Branch Medical Officer Randall Brockman announced at the Boston Symposium on Atrial Fibrillation Jan. 16. The meeting is cosponsored by the Duke Cardiac Safety Research Consortium. More information will be available soon at the consortium's website, 1www.cardiac-safety.org